Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think there has only be two trades made today. I think most people are holding and waiting for the reverse stock split.
Loose hands...sink stocks. The sellers are individual or individuals who should never have been in the stock in the first place. Begone with them. Must be running low on brewskies for the weekend.
Again another low volume day. Only 1 trade for 10,000 shares . I think everyone is waiting for the reverse split. I think this is going to be a really positive move for us!
This company has everything my other penny stocks do not have. Sales, a viable product line, and competent leadership .
I am vindicated it closed up’
Now, Now, don't let pessimism drag you down.....I refer you to the last buy of the day....150,600 shares at .06c at 15:45hr. Not a super huge buy but at least some individual or entity sees promise in the transformation of this company....I might regret not having a pile of dry powder that would allow me to jump in deeper.
So much for my last post about the stock price it is really down today! But the up side is I can more at a cheaper price!
As we get closer to the date of the reverse split I think the price will go up. There is very little shares out there now. I think everyone sees this as a good thing.
I would agree with that. My issue with the lack of trade volume is I am trying to buy more shares. I did buy 5500 more shares today but that was all I was able to get.
Someone on this board had said a while back that this is a longer term hold.....and I have believed that from the beginning....as long as they stay afloat....in the longer term this could be a very strong company.....What is happening today is expected from traders and weak holders looking for the instant pot of gold.
Trade volume has really dropped. I guess everyone is holding on till the reverse stock spilt takes place.
The press release I saw seem to hit that they are looking to change exchanges that we are traded on. Getting the stock price up is essential to make that move. Changing exchanges will also help out on the stock price. I am looking forward to the move if they can make it happen.
A trade off for growth?
These butt heads now have to pay dividends to the series c preferred shares. My God. They went thru all the hassle of flattening the share structure just to go back to it. On top of that, they no longer make profit. I don't even know what to think about this report or their planned up listing. Typically you'd wait until you were profitable to uplist. So weird.
So does no one have any opinion on what the new stock price should be? I’m trying to figure out is this going to be good for us ( stock holders) or will we that it on the chin!
Wasn't pre market....so looks like after market.
It’s done but they say it’s actually due on Monday. Should be worth the wait!
One would think so.....I did see a notification for another company I own shares in....but nothing for WNDM.
Shouldn’t their 10k be coming out today or at least a request for A delay in reporting.
That can happen as long as the share price maintains a certain level once it is uplisted....there are criteria that have to be followed to stay on a better exchange. I sure would like to see that 700K lurking at .06 disappear....it is a formidable block.
If that’s the case then the stock price should really jump! Their P&L looks really good and sales are steadily going up. This could be a really good move.
I believe your correct. In the proxy statement under corporate actions they basically said they did all this to move to a national exchange.
So what does everyone think the new trading price will be after the reverse split. I think, in theory it should be between $5-$6 per share if the stock is now trading between .05-.06 per share.
The only reason I asked about trading exchanges is other company’s I have seen , once they get their stock price up over $5 the move off the OTC to sustain that price and keep it moving up.
Split and new name...don't know about an exchange transition.....completely unfamiliar with the cost associated with that.
I just saw it was in the 8k that was just released. So we are trading 100 shares for one in he new company and the par value in the new stock is still just a penny. So should the market value then be close to $6.00 once the reverse split is done? And are we planning on changing exchanges that it is traded on?
Were did you guys see that they were doing a reverse stick split? I have not been on the board for a while and must have missed that info.
Just for the halibut I put in a bid that is higher than the current one.....just to complete my position to a nice round number....it has been up for over two hours and has not shown at all.....so what kind of shennagins are being played by broker/MM's. Some one wants to get out at six.....looks like 700K.
I am in as deep as I want to be in this sector ( medical ) as I want to be. I prefer to be well diversified.
Does anybody know a timeframe on the reverse split/name change? I wonder before or after they release their 10-K Friday?
Who cares about level 2. Buy these shares and hold them for 3 to 5 years and you'll be one happy individual.
Does anyone on this board have access to level 2....I was just wondering what is beneath that ask of 10,400 at .05c?
I see the 100K being offered got snapped up at .059c. Still very low volume considering the news. Just checked back in and I guess I wrote too soon.....looks like the "sell on news of any kind" crowd have jumped in.
As to the Spikes and dips....I have been witnessing that with another stock I own that has a low float....and yes it can be volatile. Not much reaction to the latest news...but then again I doubt this is a well followed company.
If anything the stock price will become very volatile, likely to the upside. This is because a low float always leads to Spikes and dips due to share unavailability. I've seen this a few times with other stocks.
Also, the available float which can be used for trading does not include those preferred shares until they are converted to common stock. So the 236m is still valid until Ron Nixon converts to common. He won't tho because these guys are going to be bought out for likely 10 to 20 times today's market cap.
Which according to what I can see put it at 481 Million....which after the reverse split would mean around 5 Million shares.....not a lot of shares....could put a damper on availability.....good, bad, or neutral? I don't know what the effect will be.
It is 236, but they gave put preferred shares that add another 200m when converted from preferred to common. Its in the sec filing if you're interested in reading it.
What exactly is the current O/S ?....the only info I can find indicates 236 Million. I thought the company increased that recently by a considerable amount with the Catalyst news.
Just a thought....when referring to an individual post use the reply option, as I am doing now...that will ensure no ambiguity as to whom you are directing your post.
Correction,100 to 1! So share price will be 5 dollars instead of 5 cents. Wow, that means only 2m shares outstanding. This thing is going to freaking fly.
Wow! They are changing their name to sanara medtexh and will have only 20m shares outstanding. That's a 10 to 1 reverse split. Things are getting real! I see this going up 2x to 3 x this year because of increased earnings.
Relax, I was referring toddski’s post about the reverse stock split and the new news from Friday! Just a attempt at humor not arrogance!
If your post is in reference to my post....be aware that nothing said on these boards has any effect on a stock price.....to believe so would indicate a very deep state of hubris on the part of the poster.
Looks like WNDM is stuck at .06c for a bit.
Relatively conservative response to the news so far, and that's OK.
I can't even keep up with this company. Things are changing so fast.
These guys really ought to reverse split their shares. With these new series f preffered shares there are now over 440m shares. Lol.
It's on Stockwatch as being issued this morning before market open.....taking back the 50% outside ownership of Cellerate through the issuance of Preferred shares or something to that effect....and one of the Catalyst dudes has been elected to the board of WNDM....has a lot of contacts through other companies he was, or still is, involved with. It has no effect on the common shares as far as I can see....at least not yet. I need more information.
I must have missed something. What is the news you are talking about?
Followers
|
15
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1218
|
Created
|
06/26/08
|
Type
|
Free
|
Moderators |
Wound Management Technologies, Inc. is an emerging commercial stage company with its primary products in the $5B worldwide advanced wound care market. Wound Management's primary focus is the distribution of its unique, patented collagen product, CellerateRX®, which is FDA cleared and reimbursable under Medicare Part B. Wound Management has other advanced biotech products in development including a patented resorbable bone wax line that is in late stages of development, as well as a subsidiary focused on technology for secure healthcare communications, data collaboration and storage.
Rapid revenue growth is projected from our leading FDA cleared CellerateRX wound care products, which recent market and clinical validations show to be clinically cost effective with broad uses. CellerateRX has a competitive proprietary feature and performance advantages over other collagen-based products. It is available in powder (95% collagen) and gel (65%) forms that don't need special handling (like refrigeration). It is active in all 4 phases of wound healing. As CellerateRX revenues grow, the company is positioned to become cash flow positive and profitable in 12-18 months.
CellerateRx Activated Collagen targets a multi-billion dollar domestic and international wound care market with over 60% profit margins. A large part of the growth in the wound care markets is from diabetic ulcers. In people with compromised health or circulation, the difference in wound healing can be significant. You can read through numerous evidence-based studies on the www.celleraterx.com website.
FORT WORTH, Texas, November 11, 2011 PRNewswire-FirstCall -
Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leading innovator in advanced wound care solutions, today announced that its subsidiary, Resorbable Orthopedic Products, LLC, has entered into a Development and License Agreement with Newport Beach, CA-based BioStructures, LLC to develop products for bone remodeling in the human skeletal system based on ROP's patent. BioStructures has paid ROP an initial $100K licensing fee and the agreement calls for ROP to receive additional license fees as well as royalties on sales throughout the life of the patent. Under this contract, minimum royalties will begin in 2013 and last until 2023. Initial commercial sales from this business are expected in 2013.
"This transaction allows us to combine our portfolio of proprietary biomaterials with a patented resorbable wax carrier. The combination of these products will further enhance the dynamic product lineup of BioStructures," said Russell Cook, CEO of BioStructures, LLC.
"We are pleased to have reached a license agreement with BioStructures to develop many of the orthopedic products related to Resorbable Orthopedic Products' patent on resorbable bone wax and bone void fillers. This agreement is the first commercial agreement for our subsidiary ROP and marks the start of a second product line for WNDM," said Deborah Hutchinson, president of Wound Management Technologies. "We believe that BioStructures is the right partner to develop and market these important orthopedic products and we look forward to strong success of these products in the marketplace."
ROP's patent was developed by WNDM advisor Barry Constantine and his associates and was acquired by WNDM in 2009. Mr. Constantine will oversee ROP's development responsibilities with BioStructures. "Commercialization of the BioStructures product containing the ROP technology in addition to the development and commercialization of other embodiments within the ROP patent advances the practice of orthopedic surgery," said Barry Constantine. "We are excited to see our technology move into product development with BioStructures."
Resorbable Orthopedic Products may commercialize additional products covered by the patent, including a resorbable orthopedic hemostat (resorbable bone wax), a resorbable orthopedic hemostat antimicrobial dressing and products for the veterinary market.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |